SAPCD2 and breast carcinoma: Emerging evidence has supported that the expression level of SAPCD2 may be a useful prognostic indicator of several different types of cancers, including gastric cancer, colorectal cancer, hepatocellular carcinoma, melanoma, renal cell carcinoma, nasopharyngeal carcinoma (NPC), lung cancer, and breast cancer.